GSK plc GSK
NYSE GSK
$46.50 -0.02 (-0.04%)
At close: Oct 9, 2026 · 4:00 PM EDT

Gsk (GSK) Amortizatization of Intangibles (2009 - 2016)

Updated

Analysis

Gsk (GSK) Amortizatization of Intangibles (2009 - 2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amort. of Intangibles (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn -
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn -
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 1.70 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 984.00 Mn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn -
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn -
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn -
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 600.00 Mn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn -
10 Gsk 100.33 Bn 81.91 Bn 8.24 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 179.02 Mn
Sep 30, 2016 216.91 Mn
Jun 30, 2016 193.89 Mn
Mar 31, 2016 206.39 Mn
Dec 31, 2012 921.77 Mn
Dec 31, 2011 832.93 Mn
Dec 31, 2010 842.07 Mn
Dec 31, 2009 705.66 Mn
API Access

Gsk Amortizatization of Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=GSK&period=max&api_key=YOUR_API_KEY